Cedars-Sinai Kao Autoimmunity Institute


Opening fully in 2023, this academic medical center was created to treat rheumatologic diseases and advance medical knowledge in the autoimmunology field. This grant also established the Scleroderma Program within the institute to provide interdisciplinary and integrated care for scleroderma patients and support research, outreach, training and education to help those with scleroderma.